Need a Reliable Peptide Supplier? Click HERE!!!SponsoredVisit ↗
CagriSema and BAC Water Mix

CagriSema Reconstitution Calculator

Enter the amount you want to measure. The vial buttons will highlight which vial strengths create cleaner syringe-unit measurements.

What amount do you need?

Type the target amount, then choose mg or mcg. Example: 2mg or 500mcg.

Work the dose out from body weight

Syringe size:
Possible vial strengths:
Best Match Good Match Usable Harder to Measure

Example CagriSema Titration Schedule

WeeksCagrilintideSemaglutide
Weeks 1–40.25 mg0.25 mg
Weeks 5–80.5 mg0.5 mg
Weeks 9–121.0 mg1.0 mg
Weeks 13–161.7 mg1.7 mg
Weeks 17+2.4 mg2.4 mg

Investigational fixed combination (Phase 3 REDEFINE; NDA filed Dec 2025). Both components escalate in parallel in one weekly injection; single-range dosing tables described a different drug.

Possible vial strengths:

What Is It?

CagriSema

Cagrilintide + semaglutide combination under study.

Bacteriostatic Water

Sterile water containing a bacteriostatic preservative, commonly used when preparing multi-use research vials.

How To Mix CagriSema

1
Clean

Use alcohol swabs to clean the tops of both vials.

2
Draw BAC Water

Draw the selected amount of bacteriostatic water.

3
Inject Slowly

Add the liquid slowly down the side of the vial.

4
Swirl Gently

Do not shake. Swirl gently until dissolved.

5
Store Properly

Store as directed and protect from heat and light.

Best Practices & Common Mistakes

Best Practices

  • Use sterile technique.
  • Protect from light and heat.
  • Store refrigerated when appropriate.
  • Use clean syringe-unit math before measuring.

Common Mistakes

  • Confusing milligrams with milliliters.
  • Choosing an option with awkward decimal units.
  • Using too little liquid for very small measurements.
  • Shaking the vial aggressively.

CagriSema Storage & Handling

Lyophilized Powder: −20°C (−4°F) for long-term storage (up to 24 months). Refrigeration 2–8°C (36–46°F) for short-term use (up to ~3 months). Original sealed vial in the freezer is safest.
Reconstituted Solution: 2–8°C (36–46°F), use within ~7–14 days. Keep sealed, avoid light, and do not repeat freeze-thaw cycles.

Frequently Asked Questions

In studies it's dosed once weekly with slow escalation: 0.6 mg for 4 weeks, then +0.6 mg every 4 weeks — 1.2 → 1.8 mg — typically up to a 2.4 mg maintenance dose. These are the amounts used in clinical research, shown for reference, not a recommendation. Cagrilintide is investigational and not approved; dosing belongs with a licensed clinician.
No — and that's its defining trait. Cagrilintide is a long-acting amylin analogue, a different hormone pathway from GLP-1 drugs like semaglutide. The two are often studied together (the combination is called CagriSema) because they work through complementary mechanisms. For the calculator it makes no difference — the math is the same mg-to-units conversion — but the class is what sets cagrilintide apart.
It's a once-weekly compound, with research protocols escalating to a maintenance dose of around 2.4 mg weekly and some extended schedules going higher (studies note not exceeding ~4.5 mg per dose). Because the half-life is long (~7 days), it isn't dosed daily — a single weekly injection is the studied pattern. These are research figures, not a personal recommendation.
Add BAC water slowly down the side and swirl gently until clear — never shake. A common research mix is a 5 mg vial with 2 mL (2.5 mg/mL), so a 2.4 mg dose is ~0.96 mL (96 units), or a 10 mg vial with 3 mL (~3.33 mg/mL). Moderate concentrations dissolve reliably and make fine dose adjustments easier; the calculator highlights the cleanest unit matches.
About 160 hours — roughly a week. That long half-life is exactly why it's injected once weekly rather than daily, and it means levels accumulate over the first several weeks before reaching a steady state. A single-dose calculation describes your first injection; later weekly troughs sit higher than that first amount.
Practical takeaway: If your goal involves weight management, metabolic health, recovery, physical performance, cognitive function, appearance, or general well-being, discuss it with a licensed healthcare professional. They can help you evaluate approved, evidence-based options rather than relying on an unapproved or investigational compound. This calculator is intended only for transparent research-reference calculations and does not determine an appropriate amount, recommend use, or replace professional medical guidance.

About the author

Maria Hrabina is a pharmacist and scientific reviewer with a strong interest in peptide science, pharmacology, and emerging therapeutic compounds.

Her work focuses on understanding how peptide-based compounds interact with biological signaling pathways and how they are being investigated across areas such as metabolic health, dermatology, recovery, regenerative research, and pharmaceutical development.

Maria follows research on a broad range of peptides, from compounds used in approved medicines to experimental molecules still being evaluated in laboratory, preclinical, and clinical studies.

Her approach combines scientific curiosity with critical evaluation of evidence. She believes promising mechanisms and early research deserve attention, but should not be presented as established clinical benefits until they are supported by adequate human data.

Her areas of focus include scientific literature review, mechanisms of action, pharmacology, pharmacokinetics, safety, pharmaceutical formulation, and the overall quality of evidence behind peptide-based compounds.

She is particularly interested in the process of translating an experimental molecule into a reliable pharmaceutical product — including compound characterization, purity, stability, formulation, dose selection, safety assessment, and controlled clinical trials.

Maria believes peptide science has significant long-term potential, but that its progress depends on rigorous research, high manufacturing standards, transparent safety data, and responsible scientific communication.

Through her writing, she aims to help readers understand both sides of peptide research: what makes these compounds scientifically promising and what questions remain before their potential can be considered clinically established.

Areas of interest: Peptide Science · Therapeutic Peptides · Peptide Pharmacology · Metabolic Peptides · Cosmetic Peptides · Drug Development · Pharmacokinetics · Drug Safety · Pharmaceutical Formulation · Emerging Therapies · Evidence-Based Medicine

Important: This tool is for informational and research-reference purposes only. Not intended for human or veterinary use.
← All peptides